logo
Plus   Neg
Share
Email

Endo Agrees To Additional Stay Of Litigation Against FDA - Quick Facts

Endo International plc (ENDP) announced it has agreed to an additional stay of its litigation against the U.S. FDA until December 31, 2018. The company noted that during discussions between Endo's and FDA's respective counsel on September 20, 2018, FDA advised Endo that FDA would commit to use its best efforts to finalize its clinical need determination for vasopressin by December 31, 2018 if Endo agreed to again stay the litigation until such date. Based on FDA's commitment, Endo agreed to the proposed stay. Endo agreed to FDA's prior stay requests in January 2018 and April 2018.

Matthew Maletta, Chief Legal Officer of Endo, said: "In light of FDA's commitment to Endo that FDA will use its best efforts to reach a final clinical need determination for vasopressin by December 31, 2018, we believe that a brief additional stay of our litigation is appropriate to allow FDA to complete its rulemaking process."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Justice has reached a settlement agreement with a Texas-based Taco Bell franchise owner for immigration-related discrimination against certain employees. The settlement resolves the DOJ's investigation into whether MUY Brands LLC, and a related management company, MUY Consulting Inc., violated the Immigration and Nationality Act. Starbucks is gearing up for the upcoming holiday season by introducing its 2019 holiday flavors in U.S. grocery stores. The launch of the coffee giant's holiday line-up this year includes returning holiday favorites as well as a new item. Customers can now take home products that are making a comeback such as Starbucks Holiday Blend K-Cup and Ground Coffee, Peppermint Mocha Flavored Ground Coffee, Peekay International issued a recall of 7 ounce and 14 ounce packs containing Keshav Dry Apricot food treats as they contain undeclared allergens such as sulfites, according to a statement published by The U.S. Food and Drug Administration. Consumption of the product by those allergic or having severe sensitivity to sulfites could run the risk of serious or life-threatening allergic reactions.
Follow RTT
>